Bald positive Ergebnisse?
Seite 2 von 7 Neuester Beitrag: 11.06.24 22:34 | ||||
Eröffnet am: | 24.05.14 10:30 | von: Kohlebagger | Anzahl Beiträge: | 152 |
Neuester Beitrag: | 11.06.24 22:34 | von: Biotecfan | Leser gesamt: | 58.301 |
Forum: | Hot-Stocks | Leser heute: | 17 | |
Bewertet mit: | ||||
Seite: < 1 | | 3 | 4 | 5 | 6 | 7 7 > |
HV wollen noch einige rein.
" Adherex Technologies Inc. (TSX: AHX)(OTCQB: ADHXF) today announced that the nominees listed in the management proxy circular dated April 28,2014 (the "Circular") for the Annual and Special Meeting of Shareholders were elected as directors of the Company at the Annual and Special Meeting of Shareholders held in Durham, North Carolina on May 28, 2014 (the "Meeting"). Detailed results of the vote for the election of the slate of directors are set out below:
--------------------------------------------------
Name of Nominee
Votes For
% Votes For
Votes Withheld % Votes Withheld -------------------------------------------------- Dr. Khalid Islam
15,307,719
99.90%
14,735
0.10% -------------------------------------------------- Mr. Adrian Haigh
15,307,719
99.90%
14,735
0.10% -------------------------------------------------- Mr. Chris A.
Rallis
15,307,719
99.90%
14,735
0.10% -------------------------------------------------- Mr. Rostislav
Raykov
15,307,719
99.90%
14,735
0.10% -------------------------------------------------- Mr. Steven D.
Skolsky
15,307,719
99.90%
14,735
0.10% --------------------------------------------------
Each of the other matters put to the shareholders of the Company at the Meeting, including the offer to exchange the Company's outstanding 2010 warrants and 2011 warrants, the Company's name change and the consolidation of the Company's shares (which are each described in the Circular), were passed by the requisite number of shareholder votes. It is expected that the Company's shareholders and holders of 2010 warrants and 2011 warrants will receive the applicable documentation over the coming weeks in connection with the foregoing changes. Shareholders and such warrantholders should not destroy any share certificate(s) or warrant(s) and should not submit any share certificate(s) or warrant(s) until requested to do so."
Noch einen schönen sonnigen Sonntag!
Da dürfen wir drauf gespannt sein. Ich denke aber, dass da nicht gesagt wird, alles ist zulassungreif und der Antrag erfoglt umgehend, sondern imbesten Fall noch wenige Unklarheiten bestehen,die noch zu klären sind. wichtig wäre für mich, dass das Medikamt wirksam ist (das dürfte wohl zu 99 % der Fall sein nach meinem bisherigen Wissensstand) und die therapie nicht negativ beeinflusst wird ( das würde ich 50:50 einschätzen, da ist aber nur meien Einschätzung aus der 1. Präsentation)